Avisi Technologies
Seed Round in 2022
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.
AmorSui
Seed Round in 2022
AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial and static-resistant properties, offering protection against bodily fluids while being reusable and recyclable. The company focuses on delivering high-quality, comfortable, and eco-friendly personal protective equipment that is entirely made and sourced in the USA. Additionally, AmorSui provides a platform for managing and procuring reusable kits, utilizing data analytics to monitor product life cycles, thereby helping hospitals and companies reduce costs and minimize waste while ensuring employee safety.
Nia Therapeutics
Venture Round in 2021
Nia Therapeutics, Inc. is a company focused on developing precision neurostimulation therapies aimed at treating memory impairment, particularly in patients with traumatic brain injury. Founded in 2016, Nia Therapeutics is based in Radnor, Pennsylvania. The company's innovative approach involves utilizing neurostimulation devices that interpret complex brain activity related to memory function. By providing personalized therapy through deep-brain stimulation, Nia Therapeutics aims to enhance memory restoration and improve cognitive outcomes for affected individuals.
Vesteck is a clinical stage medical device company dedicated to advancing proprietary technology in the aortic repair, structural heart, and gastrointestinal markets. The company's flagship product, the Suture-Tight™ nitinol suture delivery catheter, offers an innovative solution for endovascular aortic repair by securely suturing grafts to the aorta during initial implantation. This technology addresses critical challenges such as graft migration and leaks, which can lead to complex and costly repairs. By improving the efficacy of aortic repairs and providing significant benefits to healthcare providers, payors, and patients, Vesteck aims to enhance patient outcomes in the treatment of aortic aneurysms and related conditions.
Avisi Technologies
Seed Round in 2021
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.
Pression
Pre Seed Round in 2020
Pression is a developer of a patented, non-invasive smart compression platform known as the Wave, which aims to enhance circulation throughout the body and improve cardiac function. The primary focus of the company is to assist heart failure patients, addressing the issue of excess fluid retention, a leading cause of hospitalizations in the United States. By increasing oxygen delivery to vital organs, the Wave system seeks to enhance exercise tolerance and overall quality of life for individuals with circulatory conditions. The technology is built on established scientific principles and offers improvements over previous systems, emphasizing patient independence and health.
Bainbridge Health
Debt Financing in 2020
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.
iOrtho+
Debt Financing in 2020
iOrtho+ is a medical software company that specializes in orthopedic care through its innovative web-based application, the Mobil-Aider. This premium orthopedic app is designed to quantify joint mobility, enabling clinicians to assess a wide range of motions across multiple joints. The Mobil-Aider includes 450 tests and 1,300 references, along with 100 mobilization techniques, offering a comprehensive resource for orthopedic professionals. The application features concise descriptions, images, videos, and statistical data, as well as direct links to relevant literature, all aimed at enhancing the quality of treatments and improving clinical outcomes.
OsciFlex
Debt Financing in 2020
OsciFlex LLC, founded in 2017 and based in Philadelphia, Pennsylvania, specializes in developing a wearable medical device aimed at preventing blood clots in patients. The device functions by stimulating calf muscle contractions through a muscle stretch reflex, which promotes valve sinus recirculatory flow. This innovative approach helps to prevent venous thromboembolism (VTE), a serious condition that can lead to significant health complications. By offering an alternative to traditional anti-coagulation pharmaceuticals, which can be costly and carry risks, OsciFlex aims to enhance patient care and reduce healthcare costs associated with blood clot management.
Excision BioTherapeutics
Debt Financing in 2020
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, established in 2015. The company specializes in developing gene editing therapeutics aimed at treating life-threatening diseases caused by neurotropic viruses. Utilizing CRISPR-based technology, Excision BioTherapeutics focuses on creating advanced gene-editing medicines that can eradicate or disrupt viral genes in human patients. The company is committed to advancing these therapeutics to ensure they are safe and effective, with the goal of significantly improving the lives of individuals affected by viral infections worldwide.
Cogwear is a brain technology company focused on addressing the needs of individuals suffering from anxiety and depression. The firm is developing a next-generation wearable device that enhances traditional physical measurements by integrating cognitive and emotional insights. This innovation aims to transition brain monitoring from laboratory settings to everyday life, providing users with real-time access to clinical-grade cognitive and emotional data. Utilizing AI-powered algorithms and proprietary dry electroencephalography (EEG) sensors, the wearable comfortably and accurately measures brain activity. The device captures and analyzes brainwaves, enabling users to receive feedback on their mental state through a secure app and shareable dashboard. By unlocking valuable insights into brain health, Cogwear aspires to improve individual well-being and performance.
Pression is a developer of a patented, non-invasive smart compression platform known as the Wave, which aims to enhance circulation throughout the body and improve cardiac function. The primary focus of the company is to assist heart failure patients, addressing the issue of excess fluid retention, a leading cause of hospitalizations in the United States. By increasing oxygen delivery to vital organs, the Wave system seeks to enhance exercise tolerance and overall quality of life for individuals with circulatory conditions. The technology is built on established scientific principles and offers improvements over previous systems, emphasizing patient independence and health.
RightAir is focused on creating non-invasive ventilators specifically for patients with chronic obstructive pulmonary disease (COPD). The company's flagship product, AIR-AD, is a wearable device that resembles a vest and incorporates advanced respiratory assist technology known as cuirass ventilation. This innovative device helps alleviate the effort of breathing by generating a vacuum that lifts the chest and abdomen during inhalation while applying pressure to facilitate quicker exhalation. By adjusting the patient's natural breathing patterns during both rest and physical activity, AIR-AD aims to significantly reduce symptoms of dynamic hyperinflation, allowing COPD patients to experience relief from shortness of breath and engage in their daily activities more comfortably.
DRSLINQ is developing a mobile EKG device that is coupled to an interactive application powered by a natural language processing integrated with a machine learning platform to appropriately triage chest pain patients to the ER.
Optical Inventory Solutions
Grant in 2020
Optical Inventory Solutions specializes in the development of ViewVax, an innovative automated vaccine inventory management system. ViewVax is designed to seamlessly integrate with existing medical refrigerators in hospitals, clinics, and doctors' offices, allowing these facilities to better organize and manage their vaccine supplies. The system employs a web-connected camera that accurately counts on-hand vaccine inventory, facilitating automatic reordering and reducing excess stock levels. With its robust design capable of withstanding cold refrigeration environments, ViewVax enhances operational efficiency by streamlining the recognition of vaccines and ensuring accurate data collection, ultimately supporting medical institutions in maintaining optimal inventory management for vaccines.
Hava Health
Pre Seed Round in 2019
Hava Health, Inc. is a biotechnology company based in the United States that specializes in developing innovative solutions for nicotine addiction. The company manufactures a smoking cessation device that includes a connected vape pen designed to assist individuals in their efforts to quit smoking. This device pairs with a smartphone application called Hale, which serves as a digital support tool for users undergoing nicotine de-addiction. Through its focus on combining technology with therapeutic approaches, Hava Health aims to provide effective support for those seeking to overcome nicotine dependence.
Avisi Technologies
Seed Round in 2019
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.
MBF Therapeutics
Seed Round in 2018
MBF Therapeutics, Inc. is a veterinary oncology company that specializes in developing and commercializing innovative therapies for cancer treatment in dogs and cats. The company's product portfolio features targeted immunotherapies and small molecule drugs designed to disrupt tumor cell metabolism while sparing healthy tissues. Key products include MBFT-101, a combination therapy for sarcomas and lymphoma that utilizes a proprietary polyamine transport inhibitor alongside a potent inhibitor of ornithine decarboxylase, and MBFT-102, an immunotherapy based on the tumor suppressor/cytokine mda-7/IL24, which has shown promise in human clinical trials for various advanced cancers. Additionally, MBF Therapeutics is advancing a gene-based vaccine platform aimed at improving treatments for both cancer and infectious diseases in animals, with the potential to transform veterinary medicine. The company is located in Ambler, Pennsylvania, and maintains a strategic partnership with the Lankenau Institute for Medical Research.
Shock Analytics
Seed Round in 2016
Shock Analytics LLC is an early-stage biomedical device company based in Philadelphia, Pennsylvania, founded in 2016. The firm specializes in designing and manufacturing noninvasive devices that estimate Systemic Vascular Resistance (SVR), a critical indicator for conditions such as congestive heart failure and sepsis. By utilizing hemodynamic information, Shock Analytics aims to provide medical professionals with innovative tools to improve the treatment and management of critically and chronically ill patients. Through its focus on smarter technologies, the company seeks to transform the landscape of biomedical diagnostics and enhance patient care.
SonoSolve
Seed Round in 2016
SonoSolve is a revolutionary new device that aims to eliminate catheter-associated complications, using non-invasive sound waves to clear obstructions and biofilms within catheters. SonoSolve is the BUZZ in Blockages!
Cagent Vascular
Seed Round in 2016
Cagent Vascular, LLC is a medical device company based in Wayne, Pennsylvania, focused on developing innovative solutions for cardiovascular diseases. The company specializes in angioplasty balloons that utilize proprietary serration technology to enhance treatment outcomes. Its flagship product, the Serranator, features serrated metal strips embedded in a semi-compliant balloon, designed specifically for the treatment of atherosclerosis and conditions such as peripheral artery disease and chronic limb-threatening ischemia. By employing a minimally invasive approach, Cagent Vascular aims to improve vessel dilatation during cardiovascular interventions, ultimately enhancing patient care and quality of life. Founded in 2014, the company is dedicated to advancing intravascular technology in the medical field.
Orange Maker
Seed Round in 2016
Orange Maker, LLC is a technology company that specializes in advanced 3D printing solutions and user-friendly software development. Founded in 2013 and based in Thousand Oaks, California, the company has developed the Helios One, a high-resolution 3D printing system utilizing heliolithography technology. This innovative system caters to a diverse range of applications, including aerospace, architecture, automotive, biotech, defense, dental, education, entertainment, fashion, medical, and manufacturing. Orange Maker aims to empower designers and engineers by providing state-of-the-art tools that facilitate the seamless creation of 3D objects while maintaining design integrity. The company fosters a collaborative culture within the 3D printing community, promoting the sharing of ideas and advancements in technology.
ZSX Medical
Venture Round in 2015
ZSX Medical, LLC is a medical device development company based in Philadelphia, Pennsylvania, established in 2009. It specializes in creating bio-absorbable products for internal closure in minimally invasive surgeries. The company is focused on its flagship product, Zip-stitch, a surgical closure system designed to facilitate challenging surgical closures quickly and effectively. This device aims to enhance surgical efficiency by reducing operative time and minimizing complications such as infection, tissue adhesion, and dehiscence, compared to traditional sutures or staples. By improving surgical outcomes and reducing healthcare costs, ZSX Medical seeks to benefit both hospitals and patients.
Halo Labs
Seed Round in 2015
Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.
TowerView Health
Seed Round in 2015
TowerView helps the 1 in 3 Americans with a chronic illness manage multiple medications. TowerView’s patients receive pre-filled medication trays that fit into a connected pillbox like a K-Cup into a Keurig coffee machine. Their pillbox can sense when patients forget a dose and automatically sends a text or phone reminder. Unlike other smart pillboxes, they send patients pre-filled medication trays sourced from a pharmacy so patients never have to fill their own pillbox and they work directly with nurses​ to target outreach for non-adherent patients. TowerView is rolling out with Independence Blue Cross in January 2015 and are in advanced discussions with numerous other health plans.
Essential Medical
Seed Round in 2014
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
Infarct Reduction Technologies
Seed Round in 2014
Infarct Reduction Technologies develops a therapeutic device for ischemic pre-conditioning protocol. The company offers LifeCuff, a non-invasive manually-inflated blood pressure cuff for remote ischemic conditioning in heart attack, stroke, sepsis, liver surgery, traumatic brain injury, and other critical condition patients. The company is headquartered in Waldwick, New Jersey.
Photosonix Medical
Seed Round in 2014
Photosonix Medical is a company based in Ambler, Pennsylvania, focused on developing innovative skincare treatments for chronic bacterial infections, particularly in the context of moderate to severe acne. The company has created CLENS™, a device that synergistically combines low-level ultrasound stimulation with blue light energy to effectively target biofilms, which are often responsible for persistent skin issues. By offering a home-use treatment option, Photosonix Medical aims to empower users to manage their acne while preventing permanent skin scarring. The primary audience for its products includes dermatologists and primary care physicians who are involved in prescribing effective acne treatments.
Stabiliz Orthopaedics
Seed Round in 2014
Stabiliz Orthopaedics, LLC, founded in 2009 and based in Exton, Pennsylvania, specializes in the development and distribution of orthopedic devices. The company focuses on creating innovative enhancements to existing orthopedic medical technologies, utilizing FDA-approved methods. Their primary aim is to improve clinical outcomes and simultaneously reduce costs for healthcare systems, addressing the challenges faced by both patients and providers in the orthopedic field.
MemVu, Inc. specializes in brain health training solutions designed for individuals and families. The company offers a unique platform, MemVu.com, which allows users to upload personal photos to create customized brain games and exercises aimed at enhancing cognitive function. This innovative approach not only facilitates brain fitness but also fosters family involvement in the care of individuals with various brain health conditions. MemVu's offerings are utilized by healthcare professionals, including physicians, social workers, and psychologists, as well as institutions like hospitals, rehabilitation centers, and assisted living facilities, to support patient care and engagement. Founded in 2008, MemVu is headquartered in Yardley, Pennsylvania.
Halo Labs
Seed Round in 2014
Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.
OrthogenRx
Seed Round in 2013
OrthogenRx is a commercial-stage product development company focused on orthopedic medical devices aimed at treating musculoskeletal conditions, particularly knee joint pain. The company's primary product is an injection designed to lubricate the knee joint and alleviate mild to moderate pain for patients who have not adequately responded to conservative treatments. OrthogenRx employs a business model that leverages exclusive supply and license agreements for products available outside the United States, while also pursuing generic product approval domestically. This approach aims to reduce healthcare costs significantly by utilizing existing regulations for abbreviated approval of generic devices, similar to the process for generic drugs. By providing safe and effective non-surgical alternatives, OrthogenRx addresses the needs of patients seeking relief from joint pain.
ZSX Medical
Series A in 2013
ZSX Medical, LLC is a medical device development company based in Philadelphia, Pennsylvania, established in 2009. It specializes in creating bio-absorbable products for internal closure in minimally invasive surgeries. The company is focused on its flagship product, Zip-stitch, a surgical closure system designed to facilitate challenging surgical closures quickly and effectively. This device aims to enhance surgical efficiency by reducing operative time and minimizing complications such as infection, tissue adhesion, and dehiscence, compared to traditional sutures or staples. By improving surgical outcomes and reducing healthcare costs, ZSX Medical seeks to benefit both hospitals and patients.
Stabiliz Orthopaedics
Seed Round in 2012
Stabiliz Orthopaedics, LLC, founded in 2009 and based in Exton, Pennsylvania, specializes in the development and distribution of orthopedic devices. The company focuses on creating innovative enhancements to existing orthopedic medical technologies, utilizing FDA-approved methods. Their primary aim is to improve clinical outcomes and simultaneously reduce costs for healthcare systems, addressing the challenges faced by both patients and providers in the orthopedic field.
EyeIC
Venture Round in 2012
EyeIC, Inc. is a medical technology company focused on developing and commercializing imaging technologies for eye care applications. Based in Wayne, Pennsylvania, EyeIC serves eye care professionals and clinics by offering the MatchedFlicker device, which monitors the onset and progression of glaucoma through change detection in time series retinal photographs. The technology aligns and registers images taken at different times, creating a superimposed view that aids in accurate diagnosis. Additionally, EyeIC's software includes an easy-to-use application that streamlines image processing, interpretation, and reporting, facilitating the detection of various retinal conditions such as diabetic retinopathy and retinopathy of prematurity. Established in 2004, EyeIC aims to simplify workflows for clinicians and enhance patient care in the field of ophthalmology.
Essential Medical
Seed Round in 2011
Essential Medical is a family owned & operated business that was started in 1985. We are a broad based supplier of home medical and health related products designed with the needs of the user in mind. Within this online website you will find many different product options to meet a variety of life styles and physical conditions. If you are a home medical equipment dealer and would like to be set up to order Essential products, please click on the Prospective Dealers tab. If you would like to purchase products for yourself, family member or friend, our fine products are available through your local medical equipment dealer or pharmacy. Please consult the yellow pages of your local telephone book under Hospital and Medical Equipment.
Essential Medical
Seed Round in 2010
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in developing femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has created two primary closure devices, including MANTA, which is specifically designed to address large bore punctures ranging from 10 to 24 French. These devices are particularly relevant for procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). The innovations from Essential Medical aim to fulfill a significant need in interventional cardiology by providing efficient closure solutions that minimize complications for patients. Since October 2018, the company operates as a subsidiary of Teleflex Incorporated.